At 32.7x trailing earnings and 21.9x forward earnings, the market is clearly discounting accelerating profitability, and the 0.9 forward PEG suggests that growth is being priced at less than one times its expected rate — a classic GARP setup. An Altman Z-Score of 9 signals extreme balance sheet safety, effectively eliminating near-term solvency risk, while a 4.9 current ratio reinforces liquidity strength. With a $584M market cap and a 15.80% ROE, this is not a distressed cyclical but a financially sound industrial compounder trading at a valuation that compresses meaningfully on forward numbers. The combination of a declining forward multiple and fortress-level financial health suggests the stock is not mispriced for disaster, but arguably underappreciated for steady, capital-efficient growth.
⚠️ Financial Disclaimer:
This content is for informational purposes only and is not financial advice. Information may be delayed or inaccurate. We may earn a commission from partner links.